Antiplatelet therapy after coronary artery bypass surgery Post date 11 June 2024 ← Dual antiplatelet therapy after coronary artery bypass surgery → Gilead pays $40m to settle allegations that it delayed work on an improved HIV drug to maximise profits from an older drug